Manufacturing FDA imposes import alert on Indian plant after inspectors flag GMP failings BioSpaceOfficials sanctioned Dabur India months after FDA inspectors found bird droppings and data integrity deficiencies during an inspection of the plant.Read full story pharminent June 12, 2026 (Last updated: June 17, 2026) BioSpace Officials sanctioned Dabur India months after FDA inspectors found bird droppings and data integrity deficiencies during an inspection of the plant. Read full story Post navigation Previous: Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy winNext: Next Post Related Stories Manufacturing BMS banks on Texas for $2.3bn multi-modal manufacturing facility pharminent August 11, 2026 Manufacturing AsymBio to secure $184m to support growth in biologics manufacturing pharminent August 5, 2026 Manufacturing Lilly and Resilience invest $750M in diabetes and obesity drug device supply pharminent July 31, 2026
